Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Hanekamp Annemarie — BioNTech SE insider: 2 transactions · InsiderLens

Home / Insiders / Hanekamp Annemarie

Hanekamp Annemarie

Chief Commercial Officer at BioNTech SE · on record since May 13, 2026

Insider trading activity of Hanekamp Annemarie

Transactions on record: 2; since May 13, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 13, 2026

Figures computed from official regulatory filings — methodology.

Companies where Hanekamp Annemarie has traded

BioNTech SE2 tx · May 13, 2026

Track record of Hanekamp Annemarie

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hanekamp Annemarie

Co-insiders of Hanekamp Annemarie

Blackwood Nicola ClaireBioNTech SE
Jeggle Helmut WolfgangBioNTech SE
Jimenez KylieBioNTech SE
Low-Friedrich Iris KatharinaBioNTech SE
Morawietz AnjaBioNTech SE
Motschmann MichaelBioNTech SE
Poetting SierkBioNTech SE

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Ryan James Timothy PatrickBioNTech SE

Sahin UgurBioNTech SE

Schaffert SusanneBioNTech SE

Staudigl RudolfBioNTech SE

Tureci OzlemBioNTech SE

Wandschneider UlrichBioNTech SE

Zapata Gomez RamonBioNTech SE

Company	Filed	Type	Qty	Price	Value · USD	Src
BioNTech SE	May 13, 2026	AwardD	10,069	0.00 USD	$0	SEC
BioNTech SE	May 13, 2026	AwardD	12,586	0.00 USD	$0	SEC